https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-02 22:48:462024-11-02 22:48:46Not related to prostate cancer but really interesting: allogenic CAR-T is getting good results!
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-01 21:58:002024-11-01 21:59:52Benfo-Oxythiamine Shows Promise as a Radiosensitizer in mCRPC
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-01 21:22:142024-11-01 21:27:18Positive Phase 1 Data Supports Phase 2 of 177Lu rhPSMA-10.1 for mCRPC
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-01 21:09:172024-11-01 21:09:17Masofaniten (EPI-7386) trial was stopped
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-01 20:08:372024-11-01 20:12:58New Pipeline for Personalized Cancer Treatments
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-01 19:58:532024-11-01 20:02:10FDA Accepts New Drug Application for 3-Month Formulation of Leuprolide Mesylate for Advanced Prostate Cancer Treatment
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-10-31 18:09:212024-10-31 18:09:21Phase 2: Iodine-131 PSMA Radioligand with Enzalutamide Shows Promise in ARROW trial for metastatic castration-resistant prostate cancer (mCRPC)
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-10-30 16:43:472024-10-30 16:48:10Phase 1 Trial of STX-478 Shows Promise for PI3K-Mutated Solid Tumors with Reduced Toxicity